Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation

dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Química Biolóxica e Materiais Molecularesgl
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Química Orgánicagl
dc.contributor.authorKlajnert, Barbara
dc.contributor.authorWasiak, Tomasz
dc.contributor.authorIonov, Maksim
dc.contributor.authorFernández Villamarín, Marcos
dc.contributor.authorSousa Hervés, Ana
dc.contributor.authorCorrea, Juan
dc.contributor.authorRiguera Vega, Ricardo
dc.contributor.authorFernández Megía, Eduardo
dc.date.accessioned2018-07-06T08:08:09Z
dc.date.available2018-07-06T08:08:09Z
dc.date.issued2012-11
dc.description.abstractThe influence of a GATG (gallic acid-triethylene glycol) dendrimer decorated with 27 terminal morpholine groups ([G3]-Mor) on the aggregation process of Alzheimer's peptide has been investigated. Amyloid fibrils were formed from the Aβ 1-28 peptide and the process was monitored by a ThT assay, changes in CD spectra, and transmission electron microscopy. In the presence of [G3]-Mor, more fibrils were built and the process significantly accelerated compared with a control. The cytotoxicity of (1) Aβ and (2) the system [G3]-Mor/Aβ was monitored at different stages of the aggregation process. Prefibrillar species were more toxic than mature fibrils. [G3]-Mor significantly reduced the toxicity of Aβ, probably because of lowering the amount of prefibrillar forms in the system by speeding up the process of fibril formationgl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work was funded by the project “Biological Properties and Biomedical Applications of Dendrimers” operated within Foundation for Polish Science TEAM programme, cofinanced by the European Regional Development Fund. Financial support is also acknowledged from the Spanish MICINN (CTQ2009-10963 and CTQ2009-14146-C02-02) and the Xunta de Galicia (10CSA209021PR and CN2011/037). M.F-V. thanks the Spanish Ministry of Education for a FPU fellowship. The research was performed within the frame of the COST Action TD0802 “Dendrimers for biomedical applications.”gl
dc.identifier.citationKlajnert, B., Wasiak, T., Ionov, M., Fernandez-Villamarin, M., Sousa-Herves, A., & Correa, J. et al. (2012). Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation. Nanomedicine: Nanotechnology, Biology And Medicine, 8(8), 1372-1378. doi: 10.1016/j.nano.2012.03.005gl
dc.identifier.doi10.1016/j.nano.2012.03.005
dc.identifier.issn1549-9634
dc.identifier.urihttp://hdl.handle.net/10347/16971
dc.language.isoenggl
dc.publisherElseviergl
dc.relation.publisherversionhttps://doi.org/10.1016/j.nano.2012.03.005gl
dc.rights© 2012 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 license (http:// creativecommons.org/licenses/by-nc-nd/4.0/)gl
dc.rights.accessRightsopen accessgl
dc.subjectDendrimergl
dc.subjectAlzheimer's diseasegl
dc.subjectAβ 1-28gl
dc.subjectAmyloid peptidegl
dc.titleDendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formationgl
dc.typejournal articlegl
dc.type.hasVersionAMgl
dspace.entity.typePublication
relation.isAuthorOfPublication0f51f559-1806-45ca-945e-f4c12c3cefb9
relation.isAuthorOfPublicationfe5ace22-ce25-4507-aacf-a74fa1010319
relation.isAuthorOfPublication.latestForDiscovery0f51f559-1806-45ca-945e-f4c12c3cefb9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2012_fernandez_nanomedicine_dendrimers_reduce.pdf
Size:
1.86 MB
Format:
Adobe Portable Document Format
Description: